Basel, Switzerland Friday, September 20, 2024, 13:00 Hrs [IST] ...

JERSEY CITY, N.J., September 18, 2024--Organon enters agreement to acquire Dermavant including innovative VTAMA (tapinarof) cream, 1%, a novel, non-steroidal topical dermatologic therapy.

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

Congress in Spain were a major feature of research news last week, including those from Pfizer on it ponsegromab in cancer ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

The announced job cuts are the latest in a series of steps Bluebird has taken to preserve cash and break even financially amid slow uptake of its marketed gene therapies.

Organon (NYSE: OGN) has recently announced its acquisition of Dermavant Sciences Ltd., a company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology. The ...

Raffat is less bullish on the deal’s upside for Organon, saying he expects it to be “modest.” Dermavant was founded in 2015 as Roivant Dermatology Ltd. and changed its name the next year. The company ...

becoming an alternative to corneal replacement using donor tiss Organon is paying $175 million upfront to buy Roivant's dermatology unit Dermavant and its topical psoriasis therapy Vtama ...

Organon is paying $175 million upfront to buy Roivant's dermatology unit Dermavant and its topical psoriasis therapy Vtama, which is also under review by the FDA for atopic dermatitis. The ...